Compare Stock Earnings
Side-by-side earnings, revenue, and financial performance comparison
Takeda Pharmaceutical Company
$16.49
-1.14%
Mkt Cap: $51.9B
Avg ER Move: ±0.9%
Next Earnings
Jul 30, 2026
In 68 days
Earnings Track Record (5Q)
1 Beats
4 Misses
Whisper Beat: 20%
Last 4 Quarters
Q1'26
$0.21
✅ BEAT +0%
📈 +0.4%
$1.21T
Q4'25
$-0.03
❌ MISS -116.8%
📈 +1.6%
$1.11T
Q3'25
$151.00
✅ BEAT +75174.2%
📈 +0.9%
$1.11T
Q2'25
$-0.23
❌ MISS -37.1%
📈 +0.6%
$1.11T
Latest Revenue
$1.11T
+5.8% YoY
Gross: 48.8%
Op: 4.3%
Net: -2.2%
Lilly(Eli) & Company
$1,018.87
-0.25%
Mkt Cap: $821.9B
Avg ER Move: ±3%
Earnings Track Record (8Q)
6 Beats
2 Misses
Whisper Beat: 63%
Last 4 Quarters
Q2'26
$8.55
✅ BEAT +17.9%
📈 +3.1%
$19.80B
Q1'26
$7.54
✅ BEAT +5.2%
📈 +2.3%
$19.29B
Q1'26
$7.54
✅ BEAT +5.2%
📉 -7.8%
$19.29B
Q4'25
$7.02
✅ BEAT +10.2%
📈 +2.2%
$17.60B
Latest Revenue
$19.80B
+55.6% YoY
Gross: 81.9%
Op: 44.7%
Net: 37.4%
Johnson & Johnson
$231.74
+1.06%
Mkt Cap: $578.2B
Avg ER Move: ±0.5%
Next Earnings
Jul 15, 2026
In 53 days
Consensus EPS
$2.84
Whisper EPS
$2.90
Revenue Whisper
$23.59B
Earnings Track Record (7Q)
6 Beats
0 Misses
Whisper Beat: 29%
Last 4 Quarters
Q2'26
$2.70
✅ BEAT +0.7%
📉 -0.6%
$24.06B
Q1'26
$2.46
➖ MET +0%
📈 +0.2%
$24.56B
Q4'25
$2.80
✅ BEAT +1.4%
📈 +0.2%
$23.99B
Q3'25
$2.77
✅ BEAT +3.4%
📉 -1.1%
$23.74B
Latest Revenue
$24.06B
+9.9% YoY
Gross: 71.5%
Op: 26.6%
Net: 21.8%
📊 Head-to-Head Comparison
| Metric | TAK | LLY | JNJ |
|---|---|---|---|
| Price | $16.49 | $1,018.87 | $231.74 |
| Market Cap | $51.9B | $821.9B | $578.2B |
| EPS Beat Rate | 20% | 75% | 86% |
| Whisper Beat Rate | 20% | 63% | 29% |
| Avg ER Move | ±0.9% | ±3% | ±0.5% |
| Next EPS Consensus | -- | -- | $2.84 |
| Next EPS Whisper | -- | -- | $2.90 |
| Revenue Whisper | -- | -- | $23.59B |
| Latest Revenue | $1.11T | $19.80B | $24.06B |
| Revenue Growth YoY | +5.8% | +55.6% | +9.9% |
| Gross Margin | 48.8% | 81.9% | 71.5% |
| Operating Margin | 4.3% | 44.7% | 26.6% |
| Net Margin | -2.2% | 37.4% | 21.8% |
| Earnings Date | Jul 30, 2026 | -- | Jul 15, 2026 |
📈 Visual Comparison
EPS Surprise % (Last 8 Quarters)
Revenue Trend
Post-Earnings Price Move
Margin Comparison
⚡ Quick Stats
TAK
20% beat rate
· ±0.9% avg move
LLY
75% beat rate
· ±3% avg move
JNJ
86% beat rate
· ±0.5% avg move